Pasternak Richard C Insider Trades

Insider Trading History

Track insider trading activity for Pasternak Richard C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.7k 30,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 30,000 shares
$3.86
$1.29
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $12.9k 10,000 shares
Last Trade
Oct 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52k 10,000 shares
$5.20
$1.29
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.7k 30,000 shares
Last Trade
Jul 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 30,000 shares
$6.07
$1.29
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.7k 30,000 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 30,000 shares
$5.54
$1.29
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $19.4k 15,000 shares
Last Trade
Jun 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.1k 15,000 shares
$3.74
$1.29
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $24.5k 19,000 shares
Last Trade
Nov 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$338k 19,000 shares
$17.78
$1.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up